review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Daryl L. Davies | Q38328079 |
P2093 | author name string | Doo-Sup Choi | |
Liana Asatryan | |||
Moonnoh R Lee | |||
Mahesh M Thakkar | |||
M Saeed Dar | |||
Hyung W Nam | |||
P2860 | cites work | Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays | Q21203941 |
Genetical genomic determinants of alcohol consumption in rats and humans | Q21245326 | ||
Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes | Q24301398 | ||
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers | Q24304896 | ||
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. | Q24305024 | ||
Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs | Q24310832 | ||
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta | Q24312794 | ||
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes | Q24563287 | ||
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study | Q24645469 | ||
Crystal structure of the ATP-gated P2X(4) ion channel in the closed state | Q24657193 | ||
Allosteric control of gating and kinetics at P2X(4) receptor channels | Q28142880 | ||
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits | Q28199881 | ||
Molecular physiology of P2X receptors | Q28203477 | ||
Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans | Q28239336 | ||
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain | Q28256105 | ||
Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line | Q28262991 | ||
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat | Q28264281 | ||
Intracellular signaling pathways that regulate behavioral responses to ethanol | Q28267487 | ||
Adaptations in adenosine signaling in drug dependence: therapeutic implications | Q28271595 | ||
Cloning and tissue distribution of a novel P2X receptor from rat brain | Q28282631 | ||
Signaling at purinergic P2X receptors | Q28296741 | ||
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption | Q28299078 | ||
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice | Q28346715 | ||
Alcohol's effects on sleep in alcoholics | Q28360988 | ||
Altered hippocampal synaptic potentiation in P2X4 knock-out mice | Q28507640 | ||
Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats | Q28566486 | ||
betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption | Q28570732 | ||
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues | Q28577258 | ||
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers | Q28578407 | ||
Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics | Q28585492 | ||
Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice | Q28589507 | ||
Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice | Q28592374 | ||
Function and regulation of CREB family transcription factors in the nervous system | Q29619559 | ||
Molecular basis of long-term plasticity underlying addiction | Q29620539 | ||
The sleep-inducing effect of ethanol microinjection into the medial preoptic area is blocked by flumazenil | Q31923674 | ||
Ethanol sensitivity: a central role for CREB transcription regulation in the cerebellum | Q33265511 | ||
Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice | Q33472721 | ||
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
Possible role of adenosine in the CNS effects of ethanol | Q48726572 | ||
Mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination: possible involvement of cAMP. | Q48795091 | ||
Central adenosinergic system involvement in ethanol-induced motor incoordination in mice | Q48843955 | ||
Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. | Q48932842 | ||
Effect of rapid eye movement sleep deprivation on 5'-nucleotidase activity in the rat brain | Q49056830 | ||
Behavioral sensitivity to purinergic drugs parallels ethanol sensitivity in selectively bred mice | Q49077287 | ||
Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum | Q49132563 | ||
Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. | Q50721295 | ||
Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. | Q52032615 | ||
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum | Q60050271 | ||
Role of Adenosine A1 and A2A Receptors in the Alcohol Withdrawal Syndrome | Q60440924 | ||
Effect of acute ethanol on uptake of [3H]adenosine by rat cerebellar synaptosomes | Q69352835 | ||
Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites | Q71660122 | ||
P2 receptor expression in the dopaminergic system of the rat brain during development | Q81296867 | ||
Purinoceptors in microglia and neuropathic pain | Q36503400 | ||
Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness | Q36690694 | ||
Neurobiology of REM and NREM sleep | Q36806073 | ||
The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions | Q36917393 | ||
Ivermectin: 25 years and still going strong | Q37013824 | ||
Purinergic systems in microglia | Q37194539 | ||
Purinergic signalling and disorders of the central nervous system | Q37203929 | ||
P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes | Q37352406 | ||
Purinergic regulation of hypothalamopituitary functions | Q37397335 | ||
The glutamate homeostasis hypothesis of addiction | Q37538517 | ||
Adenosine receptors as drug targets | Q37691817 | ||
Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination | Q38346916 | ||
An antagonist-insensitive P2X receptor expressed in epithelia and brain | Q38362921 | ||
Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin | Q39989811 | ||
Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action | Q40255930 | ||
Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes | Q40408692 | ||
Subunit Arrangement in P2X Receptors | Q40629382 | ||
Ivermectin, an unconventional agonist of the glycine receptor chloride channel | Q40816595 | ||
Single and repeated episodes of ethanol withdrawal increase adenosine A1, but not A2A, receptor density in mouse brain | Q40854789 | ||
Endogenous opioid systems and alcohol addiction | Q41353548 | ||
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia | Q41624006 | ||
Adenosinergic modulation of rat basal forebrain neurons during sleep and waking: neuronal recording with microdialysis | Q41709009 | ||
Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. | Q41744358 | ||
Possible role of mouse cerebellar nitric oxide in the behavioral interaction between chronic intracerebellar nicotine and acute ethanol administration: observation of cross-tolerance | Q42167584 | ||
A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors | Q33601789 | ||
Nucleoside transporters: molecular biology and implications for therapeutic development | Q33632764 | ||
Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. | Q33699186 | ||
Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade | Q33703262 | ||
Interoceptive effects of alcohol require mGlu5 receptor activity in the nucleus accumbens | Q33752076 | ||
The dopamine hypothesis of reward: past and current status | Q33756130 | ||
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. | Q33788860 | ||
avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans | Q33887549 | ||
ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes | Q34035612 | ||
Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. | Q34035647 | ||
Purinergic nerves | Q34052179 | ||
The neurobiology of slow synaptic transmission | Q34100272 | ||
Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors | Q34128759 | ||
The role and regulation of adenosine in the central nervous system | Q34205330 | ||
Adenosine analogs and sleep in rats | Q34266559 | ||
The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms | Q34276389 | ||
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons | Q34296118 | ||
Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling | Q34330621 | ||
Sleep, sleepiness, and alcohol use. | Q34389701 | ||
A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. | Q34431207 | ||
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. | Q34456094 | ||
Adenosine and sleep-wake regulation | Q34550187 | ||
Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation | Q34562779 | ||
Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats | Q34630525 | ||
Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. | Q34868702 | ||
Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes | Q35042484 | ||
Ivermectin and filariasis | Q35095257 | ||
Adenosine in the spinal cord and periphery: release and regulation of pain | Q35145661 | ||
Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol | Q35597338 | ||
Recent advances in the neurobiology of alcoholism: the role of adenosine | Q35632063 | ||
The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. | Q35888462 | ||
A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain | Q36029867 | ||
Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs | Q36094581 | ||
Ivermectin 20 years on: maturation of a wonder drug | Q36242572 | ||
Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. | Q42439356 | ||
Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats | Q42453428 | ||
Role of wake-promoting basal forebrain and adenosinergic mechanisms in sleep-promoting effects of ethanol. | Q42469923 | ||
Effect of acute ethanol on release of endogenous adenosine from rat cerebellar synaptosomes | Q42491405 | ||
Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro | Q42492222 | ||
Release of endogenous glutamate from rat cerebellar synaptosomes: interactions with adenosine and ethanol | Q42498493 | ||
Adenosine and sleep homeostasis in the Basal forebrain. | Q42499140 | ||
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system | Q42503104 | ||
Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats | Q42523450 | ||
Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels | Q42617502 | ||
Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release | Q43186230 | ||
Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors | Q43195222 | ||
Motivational effects of ethanol in DARPP-32 knock-out mice. | Q43517475 | ||
Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor | Q43728861 | ||
Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. | Q43823453 | ||
Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. | Q43978573 | ||
Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent | Q44030560 | ||
Role of adenosine receptors in spinal G-protein activation after peripheral nerve injury | Q44096141 | ||
Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice | Q44223724 | ||
Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. | Q44228562 | ||
The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats | Q44708704 | ||
Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure | Q44792331 | ||
Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. | Q44844941 | ||
Dual effects of ATP on rat hippocampal synaptic plasticity | Q44849613 | ||
Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. | Q44911155 | ||
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. | Q44982517 | ||
Ethanol operant self-administration in rats is regulated by adenosine A2 receptors | Q45057379 | ||
Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation | Q45138309 | ||
The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism | Q45153616 | ||
Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits | Q45247897 | ||
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders | Q45365301 | ||
Adenosine is required for ethanol-induced heterologous desensitization. | Q45950357 | ||
Release of adenosine by activation of NMDA receptors in the hippocampus. | Q45964014 | ||
Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons | Q46119603 | ||
Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. | Q46497048 | ||
Blockade of adenosine and dopamine receptors inhibits the development of rapid tolerance to ethanol in mice. | Q46571137 | ||
Drugs for relapse prevention of alcoholism: ten years of progress | Q46762261 | ||
Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. | Q46890952 | ||
Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice | Q46942857 | ||
Adenosinergic modulation of ethanol-induced motor incoordination in the rat motor cortex | Q47773927 | ||
Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain | Q48148868 | ||
Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain | Q48162008 | ||
Co-modulation of acute ethanol-induced motor impairment by mouse cerebellar adenosinergic A1 and GABA(A) receptor systems | Q48365370 | ||
The anatomy of the cerebellum | Q48396422 | ||
Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats | Q48398090 | ||
Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study. | Q48448903 | ||
Involvement of kappa-opioids in the mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination | Q48472859 | ||
Behavioral interaction between nicotine and ethanol: possible modulation by mouse cerebellar glutamate | Q48490410 | ||
The striatal adenosinergic modulation of ethanol-induced motor incoordination in rats: possible role of chloride flux | Q48557910 | ||
Comparison of ethanol preference and neurochemical measures of mesolimbic dopamine and adenosine systems across different strains of mice | Q48599837 | ||
P433 | issue | 4 | |
P921 | main subject | alcohol consumption | Q2647488 |
P304 | page(s) | 584-594 | |
P577 | publication date | 2011-01-11 | |
P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
P1476 | title | Implication of the purinergic system in alcohol use disorders | |
P478 | volume | 35 |
Q34155813 | Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1 |
Q48029142 | Adenosine and glutamate in neuroglial interaction: implications for circadian disorders and alcoholism |
Q35951700 | Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders |
Q37462660 | Adenosine signaling in striatal circuits and alcohol use disorders |
Q36754645 | Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum |
Q34068934 | Adenosinergic regulation of striatal clock gene expression and ethanol intake during constant light |
Q43200833 | Alcohol and Caffeine: The Perfect Storm |
Q33649945 | Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice |
Q95943778 | Cortical astrocytes regulate ethanol consumption and intoxication in mice |
Q58791740 | DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests |
Q61804383 | Ginsenosides Act As Positive Modulators of P2X4 Receptors |
Q90265889 | Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4 |
Q36733426 | Increased brain uptake and oxidation of acetate in heavy drinkers |
Q36024293 | Ivermectin reduces alcohol intake and preference in mice. |
Q37742174 | Label-Free Neuroproteomics of the Hippocampal-Accumbal Circuit Reveals Deficits in Neurotransmitter and Neuropeptide Signaling in Mice Lacking Ethanol-Sensitive Adenosine Transporter |
Q38718932 | Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models |
Q44313659 | Metabolic products of [2-(13) C]ethanol in the rat brain after chronic ethanol exposure |
Q33718454 | P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology. |
Q34403131 | P2X4 receptor regulates alcohol-induced responses in microglia |
Q27021285 | P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders |
Q30454042 | Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin |
Q37059156 | Preclinical Medication Development: New Targets and New Drugs |
Q50327421 | Purinergic Signaling in Neuron-Astrocyte Interactions, Circadian Rhythms, and Alcohol Use Disorder |
Q27024533 | Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. |
Q52686702 | Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice. |
Q34671783 | Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes |
Q37576300 | Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol |
Q36340781 | Sex-Specific Regulation of Depression, Anxiety-Like Behaviors and Alcohol Drinking in Mice Lacking ENT1. |
Q27027640 | The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies |
Q45864839 | The adenosine A2A receptor agonist CGS 21680 decreases ethanol self-administration in both non-dependent and dependent animals |
Q34958402 | Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling |
Search more.